Breo Ellipta: Asthma HCP Banner Ad

Brand: Breo Ellipta (fluticasone furoate and vilanterol), Inhalation Powder
Parent Company: GSK
Drug Type: Boxed Warning
Drug Category: Immunology
Campaign: Post-Launch
Targeting: HCPs
Patient Website:
HCP Website:

This 300×250 Breo Ellipta HCP ad is fairly conservative, likely due to the fact that it is a boxed warning drug (“black box”). It tries to conveys its main message right in the banner, although placing 31 words (frame 5 in the screenshot, not counting the logo and scrolling ISI), or 22 (last frame) on a banner ad is never a good idea.